Professional Pharmacology and Pharmacy Organization Responses to theDobbs v. JacksonSupreme Court Ruling

Abstract ID 129036 Poster Board 001 Objective/Hypothesis: The US Supreme Court's decision in Dobbs v. Jackson Women's Health Organization has sparked significant changes in reproductive healthcare laws, allowing individual states to regulate abortion rights. This study focuses on the responses of professional pharmacology and pharmacy organizations in the US to this landmark decision, recognizing its potential to influence healthcare education and training. This research aims to broadly establish the response of pharmacology and pharmacy organizations to the impact of the Dobbs decision by analyzing released statements. Design/Approach/Methods: An online search of responses to the Dobbs decision was conducted on organizations' official websites and social media pages. Search strings used included terms pertaining to abortion, Dobbs v. Jackson, or Roe v. Wade. This study only included US-based professional organizations within the field of pharmacology and pharmacy. Statements were analyzed using descriptive statistics and qualitatively via thematic analysis using the Pillars of Reproductive Wellbeing by Power To Decide, a non-profit organization committed to ensuring all people have the power to decide if, when, and under what circumstances to become pregnant and have children. These pillars include 1) autonomy 2) control 3) respect, and 4) systems of support. Statements were also examined for diversity, equity, and inclusion (DEI) in reproductive healthcare. Results: An initial evaluation was conducted on a total of sixteen professional pharmacology and pharmacy organizations within the US to assess their responses to the Dobbs decision. Nine out of sixteen organizations released an official statement. Seven organizations addressed autonomy, with common subthemes addressing protecting citizens with individual freedom and privacy between patients and healthcare providers. Four organizations addressed control, with a common subtheme of broader implications to reproductive healthcare. Acknowledgement of respect within these statements was lacking. Eight organizations addressed systems of support, with common subthemes including calls to action, advocacy for evidence-based resources, and creating effective leaders. Five organizations released statements directly referring to equity, including subthemes of equitable access to healthcare and disproportionate access to historically marginalized groups. Conclusion: This study explored responses from prominent pharmacology and pharmacy organizations to the Dobbs decision, a ruling with profound implications for reproductive healthcare akin to the Roe v. Wade decision. Roe v. Wade has long stood as a hot political platform, and the recent challenge has ignited discussions on various fronts within the healthcare community. A substantial focus emerged on the 14th Amendment's right to privacy, with autonomy and systems of support being prominent themes across organizational statements. This discourse often centered around protecting individual freedoms and advocating for shared decision-making. An opportunity to fill gaps in addressing control, respect, and equity has also been presented in the context of reproductive healthcare. This study underscores the pivotal role these organizations play in shaping healthcare policies, calling for a collective commitment to autonomy, control, systems of support, respect, and equity in the evolving landscape of reproductive healthcare rights.